Replay announces partnership between product company Syena and JURA Bio to advance T cell ...
Replay announces partnership between product company Syena and JURA Bio to advance T cell receptor NK therapies in cancer
Source: smdailyjournal.com
Stay updated with breaking news from Everett Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replay announces partnership between product company Syena and JURA Bio to advance T cell receptor NK therapies in cancer
– Updated data from Phase 1b/2 trials include 151 patients with acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes and other hematological malignancies –– Relapse-free survival was 87% at one year in a group of 71 patients who received the preferred conditioning regimen being used in the P...